Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Klepser

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|August 15, 2001
Antifungal resistance among Candida speciesM E Klepser
Pharmacotherapy|August 15, 2001
New insights in medical mycology: focus on fungal infections. IntroductionM E Klepser
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 7, 1999
The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapyR E Lewis, M E Klepser
Drugs|January 1, 1997
Drug treatment of HIV-related opportunistic infectionsM E Klepser, T B Klepser
Journal of Clinical Microbiology|November 18, 1998
Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994M E Klepser, M A Pfaller
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 25, 1999
Unsafe and potentially safe herbal therapiesT B Klepser, M E Klepser
Connecticut Medicine|June 1, 1995
The use of zidovudine to prevent perinatal transmission of HIVM E Klepser, R Quintiliani, C H Nightingale
Connecticut Medicine|August 1, 1994
Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeaeM E Klepser, R Quintiliani, C H Nightingale
Trends in Microbiology|September 19, 1997
Update on antifungal resistanceM E Klepser, E J Ernst, M A Pfaller
Antimicrobial Agents and Chemotherapy|March 18, 2000
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformansE J Ernst, M E Klepser, M A Pfaller
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|August 15, 2001
Antifungal resistance among Candida speciesM E Klepser
Pharmacotherapy|August 15, 2001
New insights in medical mycology: focus on fungal infections. IntroductionM E Klepser
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 7, 1999
The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapyR E Lewis, M E Klepser
Drugs|January 1, 1997
Drug treatment of HIV-related opportunistic infectionsM E Klepser, T B Klepser
Journal of Clinical Microbiology|November 18, 1998
Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994M E Klepser, M A Pfaller
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 25, 1999
Unsafe and potentially safe herbal therapiesT B Klepser, M E Klepser
Connecticut Medicine|June 1, 1995
The use of zidovudine to prevent perinatal transmission of HIVM E Klepser, R Quintiliani, C H Nightingale
Connecticut Medicine|August 1, 1994
Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeaeM E Klepser, R Quintiliani, C H Nightingale
Trends in Microbiology|September 19, 1997
Update on antifungal resistanceM E Klepser, E J Ernst, M A Pfaller
Antimicrobial Agents and Chemotherapy|March 18, 2000
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformansE J Ernst, M E Klepser, M A Pfaller
Pageof 5